Scribe Therapeutics Inc. (SCTX) vs Vanda Pharmaceuticals Inc. (VNDA)

A side-by-side comparison of Scribe Therapeutics Inc. and Vanda Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

SCTX

Scribe Therapeutics Inc.

$264M

$16.33HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

VNDA

Vanda Pharmaceuticals Inc.

$272M

$4.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — SCTX vs VNDA

growth of $100 · dividends reinvested · last 1y

SCTX +8.1% (+8.1%/yr)VNDA -14.6% (-14.6%/yr)SCTX compounded faster over this window

SCTX VNDA

Metrics side by side

Total return (annualized)

Metric	SCTX	VNDA
Total return (1Y)	N/A	-15.59%
Total return CAGR (3Y)	N/A	0.89%
Total return CAGR (5Y)	N/A	-23.91%
Total return CAGR (10Y)	N/A	-11.90%

SCTX is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full SCTX analysis Full VNDA analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.